Bioventix PLC
LSE:BVXP

Watchlist Manager
Bioventix PLC Logo
Bioventix PLC
LSE:BVXP
Watchlist
Price: 1 775 GBX -3.53% Market Closed
Market Cap: 92.7m GBX

Operating Margin
Bioventix PLC

76.8%
Current
78%
Average
-3.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
76.8%
=
Operating Profit
10.1m
/
Revenue
13.1m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
UK
Bioventix PLC
LSE:BVXP
92.7m GBP
77%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
395.4B USD
33%
US
Amgen Inc
NASDAQ:AMGN
171.5B USD
34%
US
Gilead Sciences Inc
NASDAQ:GILD
153.5B USD
39%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.9B USD
39%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.6B USD
28%
AU
CSL Ltd
ASX:CSL
86.6B AUD
26%
NL
argenx SE
XBRU:ARGX
46.7B EUR
22%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
53.6B USD
8%
No Stocks Found

Bioventix PLC
Glance View

Market Cap
92.7m GBX
Industry
Biotechnology

Bioventix Plc engages in the development and supply of antibodies. The company is headquartered in Farnham, Surrey and currently employs 17 full-time employees. The company went IPO on 2014-04-29. The principal activity of the Company is the development and supply of antibodies. The firm specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics, such as in automated immunoassays used in blood testing. The firm offers a portfolio of antibodies to customers for both commercial use and research and development (R&D) purposes, for the diagnosis or monitoring of a range of conditions, including heart disease, cancer, fertility, thyroid function and drug abuse. The firm also supplies antibody products and services to multinational clinical diagnostics companies. The firm sells its products through direct sales and through distributors.

BVXP Intrinsic Value
2 098.86 GBX
Undervaluation 15%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
76.8%
=
Operating Profit
10.1m
/
Revenue
13.1m
What is the Operating Margin of Bioventix PLC?

Based on Bioventix PLC's most recent financial statements, the company has Operating Margin of 76.8%.

Back to Top